Company Export Data of United States History Records | United States Exporter History Records Company of Glenmark Pharmaceuticals Inc Us Data

39 PALLETS 2365 CARTONS PH ARMACEUTICALS AS UNDER OMEP RAZOLE DR CAP 20MG 1000 NDC C ODE:68462039610 FDA PRODUCT C ODE NO.:62KCF10 HTS NO.3004. 90.9255 ANDA NO.:91672 THERA PEUTICE USE: -TREATMENT OF TR EAT GASTROESOPHAGEAL REFLUX DISEASE OMEPRAZOLE DR CAP 4 0MG 90 NDC CODE:68462039790 FDA PRODUCT CODE NO.:62KCF10 HTS NO.3004.90.9255 ANDA NO. :91672 THERAPEUTICE USE: -TR EATMENT OF TREAT GASTROESOPHA GEAL REFLUX DISEASE ONDANS ETRON ODT 8MG 30UD NDC CODE:6 8462015813 FDA PRODUCT CODE.: -61 T C A 26 H. T. S NO.: 3 004.90.92.40 ANDA NO.:-78-152 THERAPEUTICE USE:-ANTI -EME TIC TROSPIUM CL TAB 20MG 60 NDC CODE:68462046160 FDA PR ODUCT CODE NO.:-61 K C A 69 H. T. S NO.: 3004.49.00.70 A NDA NO.:-91-575 THERAPEUTICE USE:- TREATMENT OF VENOUS DI SEASES URINARY INCONTINENCE THERAPY GABAPENTIN TAB 600M G 500 NDC CODE:68462012605 F DA PRODUCT CODE:NO : 61 N C A 69 HTS NO.3004.90.9236 ANDA NO.:-77-662 THERAPEUTICE US E:-ANTICONVULSANT MARLISSA TAB 0.15/0.03MG 84 NDC CODE:6 8462038829 FDA PRODUCT CODE N O.: 64 G D A 29 H. T. S NO.: 3006.60.0000 ANDA NO.: 0914 52 THERAPEUTICE USE: ORAL CO NTRACEPTIVE COMMERCIAL & CU STOM INVOICE NO. F22452006327 DT. 24.03.2024 F22452006328 DT. 24.03.2024 F22452006310 D T. 23.03.2024 S/BILL NO: 8615 589 DT 25-MAR-2024 S/BILL NO: 8615426 DT 25-MAR-2024 S/BIL L NO: 8615425 DT 25-MAR-2024 NET WT.5979.660 KGS 02 DATA LOGGERS SET TEMPERATURE : + 20 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JER SEY MAHWAH - 07430 USA

26 PALLETS 3051 CARTONS PH ARMACEUTICALS AS UNDER ROSU VASTATIN TAB 5MG 90 NDC CODE: 68462026190 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO.: 079 172 THERAPEUTICE USE: - TO T REAT HIGH CHOLESTEROL AND REL ATED CONDITIONS, AND TO PREVE NT CARDIOVASCULAR DISEASE ROSUVASTATIN TAB 5MG 1000 NDC CODE:68462026110 FDA PRODUCT CODE NO.: 61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA N O.: 79172 THERAPEUTICE USE: T O TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO P REVENT CARDIOVASCULAR DISEASE . ROSUVASTATIN TAB 40MG 500 NDC CODE:68462026405 61 J C A 16 3004.49.00.10 79172 T O TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO PR EVENT CARDIOVASCULAR DISEASE ROSUVASTATIN TAB 40MG 30 N DC CODE:68462026430 FDA PRODU CT CODE NO.:61 J C A 16 H. T . S NO.: 3004.49.00.10 ANDA NO.: 079172 THERAPEUTICE USE: - TO TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DIS EASE ROSUVASTATIN TAB 5MG 1 000 NDC CODE:68462026110 FDA PRODUCT CODE NO.: 61 J C A 1 6 H. T. S NO.: 3004.49.00.10 ANDA NO.: 79172 THERAPEUTIC E USE: TO TREAT HIGH CHOLESTE ROL AND RELATED CONDITIONS, A ND TO PREVENT CARDIOVASCULAR DISEASE. COMMERCIAL & CUST OM INVOICE NO. F22452006291 D T. 22.03.2024 F22452006292 DT . 22.03.2024 S/BILL NO: 85873 72 DT 23-MAR-2024 S/BILL NO: 8587363 DT 23-MAR-2024 NET WT .4,880.88 KGS 26 DATA LOGGER S SET TEMPERATURE : +20 DEG REES NOTIFY PARTY:2 GLENMA RK SPECIALTY S.A. SWITZERLAND (GSSA) PLACE DU PORT 2 NEUC HATEL - 2000 SWITZERLAND

2 PALLETS 60 CARTONS PHARM ACEUTICALS AS UNDER ROSUVAS TATIN TAB 40MG 500 NDC CODE:6 8462026405 61 J C A 16 3004. 49.00.10 79172 TO TREAT HIGH CHOLESTEROL AND RELATED COND ITIONS, AND TO PREVENT CARDI OVASCULAR DISEASE COMMERCIA L & CUSTOM INVOICE NO. F22452 006329 DT. 24.03.2024 S/BILL NO: 8615583 DT 25-MAR-2024 NE T WT.295.49 KGS 02 DATA LOGGE RS SET TEMPERATURE : +20 DE GREES NOTIFY PARTY:2 GLENM ARK SPECIALTY S.A. SWITZERLAN D (GSSA) PLACE DU PORT 2 NEU CHATEL - 2000 SWITZERLAND

19 PALLETS 1637 CART ONS PHARMACEUTICALS AS UNDE R ROSUVASTATIN TAB 5MG 1000 NDC CODE:68462026110 FDA PR ODUCT CODE NO.: 61 J C A 16 H. T. S NO.: 3004.49.00.10 A NDA NO.: 79172 THERAPEUTICE U SE: TO TREAT HIGH CHOLESTEROL AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DI SEASE. ROSUVASTATIN TAB 5MG 90 NDC CODE:68462026190 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO.: 079172 THERAPEUTIC E USE: - TO TREAT HIGH CHOLES TEROL AND RELATED CONDITIONS, AND TO PREVENT CARDIOVASCUL AR DISEASE COMMERCIAL & CUS TOM INVOICE NO. F22352000973 DT. 08.06.2022 NET WT. 2,057 .62 KGS 19 DATA LOGGERS S ET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK S PECIALTY S.A. SWITZERLAND (GS SA) PLACE NUMA-DROZ 2 NEUCHA TEL - 2000 SWITZERLAND S/B ILL NO: 2009620 DT: 09-JUN-22

58 PALLETS 4577 CARTONS PH ARMACEUTICALS AS UNDER TOPI RAMATE TAB 50MG 500 NDC CODE: 68462015305 FDA PRODUCT CODE NO.: 61 M C A 40 H. T. S NO. : 3004.49.00.20 ANDA NO.:077 627 THERAPEUTICE USE: ANTICO NVULSANT TOPIRAMATE TAB 50M G 60 NDC CODE:68462015360 FD A PRODUCT CODE NO.:-61 M C A 40 H. T. S NO.: 3004.49.00.2 0 ANDA NO.:- 77-627 THERAPEU TICE USE:-ANTICONVULSANT O XCARBAZEPINE TAB 600MG 100 ND C CODE:68462013901 FDA PRODUC T CODE NO.:-61 M C A 45 H. T . S NO.: 3004.90.92.30 ANDA NO.:-77-802 THERAPEUTICE USE: -ANTI CONVULSANT AGENT OXC ARBAZEPINE TAB 300MG 100 NDC CODE:68462013801 FDA PRODUCT CODE NO.:-61 M C A 45 H. T. S NO.: 3004.90.92.30 ANDA NO .:-77-802 THERAPEUTICE USE:-A NTI CONVULSANT AGENT PRAVA STATIN SOD TAB 40MG 500 NDC C ODE:68462019705 FDA PRODUCT C ODE NO.: 61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA NO. : 77-987 THERAPEUTICE USE: H YPOLIPDAEMIC POTASSIUM CL E R TAB 20MEQ 100 NDC CODE:6846 2047201 FDA PRODUCT CODE NO.: 65 R C A 14 H. T. S NO.: 3 004.90.9190 ANDA NO.: 203562 THERAPEUTICE USE: - TO TREAT OR PREVENT LOW AMOUNTS OF PO TASSIUM IN THE BLOOD CARVE DILOL TAB 6.25MG 500 NDC CODE :68462016305 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO .: 3004.90.92.20 ANDA NO.:- 78-251 THERAPEUTICE USE:-BET A- ADRENOACEPTOR ANTAGONIST OXCARBAZEPINE TAB 600MG 100 NDC CODE:68462013901 FDA PR ODUCT CODE NO.:-61 M C A 45 H. T. S NO.: 3004.90.92.30 A NDA NO.:-77-802 THERAPEUTICE USE:-ANTI CONVULSANT AGENT OMEPRAZOLE DR CAP 40MG 30 ND C CODE:68462039730 FDA PRODUC T CODE NO.: 62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO.: 91672 THERAPEUTICE USE: - TR EATMENT OF TREAT GASTROESOPHA GEAL REFLUX DISEASE COMMER CIAL & CUSTOM INVOICE NO. F22 352000936 DT. 06.06.2022 F223 52000937 DT. 06.06.2022 F2235 2000938 DT. 06.06.2022 F22352 000942 DT. 06.06.2022 S/BILL NO: 1939395 DT 06-JUN-22 S/BI LL NO: 1939400 DT 06-JUN-22 S /BILL NO: 1939468 DT 06-JUN-22 S/BILL NO: 1945362 DT 07-JUN -2022 NET WT: 11,188.47 KGS 02 DATA LOGGERS SET TEMPERA TURE : +18 DEGREES NOTIFY PAR TY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, N EW JERSEY MAHWAH - 07430 USA

22 PALLETS 1497 CARTONS PH ARMACEUTICALS AS UNDER CHLO RPROMAZINE HCL TAB 100MG 100 NDC CODE:68462086401 61 T C A 04 3004.90.92.40 212144 TO TREAT PSYCHOTIC DISORDERS SU CH AS SCHIZOPHRENIA OR MANIC -DEPRESSION IN ADULTS EZET IMIBE-SIMVA TAB 10/80MG 30 ND C CODE:68462032430 FDA PRODUC T CODE NO.: 61 J D C 15 H. T . S NO.: 3004.49.00.10 ANDA NO.: 208699 THERAPEUTICE USE: - THIS COMBINATION MEDICATIO N IS USED TO HELP LOWER BAD CHOLESTEROL AND FATS (SUCH AS LDL, TRIGLYCERIDES) AND RAIS E GOOD CHOLESTEROL (HDL) IN THE BLOOD. EZETIMIBE WORKS BY REDUCING THE AMOUNT OF CHOLE STEROL YOUR BODY ABSORBS FROM YOUR DIET. SIMVASTATIN BELO NGS TO A GROUP OF DRUGS KNOWN AS STATINS. IT WORKS BY RE DUCING THE AMOUNT OF CHOLESTE ROL MADE BY THE LIVER. FRO VATRIPTAN SUCCINATE TAB 2.5MG 9 NDC CODE:68462069497 FDA P RODUCT CODE NO.:60 L C A 93 H. T. S NO.: 3004.90.92.28 A NDA NO.:204730 THERAPEUTICE U SE: - USE:THE TREATMENT OF M IGRAINE HEADACHES AND FOR SHO RT TERM PREVENTION OF MENSTR UAL MIGRAINE CARVEDILOL TAB 25MG 500 NDC CODE:6846201650 5 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90 .92.20 ANDA NO.:- 78-251 THE RAPEUTICE USE:-BETA- ADRENOA CEPTOR ANTAGONIST TOPIRAMA TE ER CAP (Q) 25MG 30 NDC COD E:68462037230 3004.49.00.20 61 M C B 40 210278 PRAVAST ATIN SOD TAB 80MG 90 NDC CODE :68462019890 FDA PRODUCT CODE NO.:-61 J C A 13 H. T. S NO .: 3004.90.92.20 ANDA NO.:-7 7-987 THERAPEUTICE USE:-HYPO LIPDAEMIC RUFINAMIDE TAB 40 0MG 120 NDC CODE:68462071408 61 M C A 99 3004.90.92.30 2 05075 TO USED WITH OTHER MED ICATIONS TO PREVENT OR CONTRO L SEIZURES (EPILEPSY) ASSOCI ATED WITH LENNOX-GASTAUT SYN DROME (LGS PRAVASTATIN SOD TAB 10MG 500 NDC CODE:6846201 9505 FDA PRODUCT CODE NO.:-6 1 J C A 13 H. T. S NO.: 3004 .90.92.20 ANDA NO.:-77-987 T HERAPEUTICE USE:-HYPOLIPDAEMI C COMMERCIAL & CUSTOM INVOI CE NO. F22387000307 DT. 31.05 .2022 F22387000309 DT. 31.05. 2022 F22387000310 DT. 31.05.2 022 F22387000316 DT. 31.05.20 22 F22387000317 DT. 31.05.202 2 F22387000320 DT. 31.05.2022 F22387000329 DT. 31.05.2022 S/BILL NO: 4007990 DT:02/06 /2022 S/BILL NO: 4007992 DT: 02/06/2022 S/BILL NO: 400799 3 DT:02/06/2022 S/BILL NO: 4007995 DT:02/06/2022 S/BILL NO: 4007996 DT:02/06/2022 S/BILL NO: 4007997 DT:02/06/ 2022 S/BILL NO: 4007999 DT: 02/06/2022 NET WT: 2,701.12 K GS 08 DATA LOGGERS HUMIDITY: 65% SET TEMPERATURE : +18 DEG REES TEMPERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTI CALS INC 750, CORPORATE DRIVE , NEW JERSEY MAHWAH - 07430 USA.

7 PALLETS 643 CARTON S PHARMACEUTICALS AS UNDER ATOVAQUONE ORAL SUSP 750MG/ 5ML 210ML NDC CODE:6846204212 1 FDA PRODUCT CODE NO.: 62 L C L 44 H. T. S NO.: 3004.90 .92.90 ANDA NO.: 209685 USED TO PREVENT OR TREAT A SERIOU S LUNG INFECTION CALLED PNEUM OCYSTIS PNEUMONIA (PCP). THIS MEDICATION HELPS TO STOP IN FECTION SYMPTOMS SUCH AS FEVE R, COUGH, TIREDNESS, AND SHOR TNESS OF BREATH. COMMERCIA L & CUSTOM INVOICE NO. F22335 000936 DT. 31.05.2022 NET WT. 2,361.10 KGS 07 DATA LOGGER S SET TEMPERATURE : +18 DEG REES NOTIFY PARTY:2 GLENMA RK SPECIALTY S.A. SWITZERLAND (GSSA) PLACE NUMA-DROZ 2 NE UCHATEL - 2000 SWITZERLAND S/BILL NO: 1924315 DT: 06-JUN -22

48 PALLETS 2032 CARTONS P HARMACEUTICALS AS UNDER ALY ACEN 1/35 TAB 1/0.035MG 84 ND C CODE:68462039429 FDA PRODUC T CODE NO.: 65 J D A 24 H. T . S NO.: 3006.60.00.00 ANDA NO.: 091634 THERAPEUTICE USE: ORALCONTRACEPTIVE NORETH ACE/EE TAB 1MG/5MCG 90 NDC CO DE:68462065790 FDA PRODUCT CO DE NO.: 65 J D A 25 H. T. S NO.: 3006.60.00.00 ANDA NO.: 203038 THERAPEUTICE USE: - TREATMENT OF MODERATE TO SEVE RE VASOMOTOR SYMPTOMS DUE TO MENOPAUSE; OSTEOPOROSIS PREV ENTION OMEPRAZOLE DR CAP 40 MG 1000 NDC CODE:68462039710 FDA PRODUCT CODE NO.:62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO.:91672 THERAPEUTICE U SE: - TREATMENT OF TREAT GAS TROESOPHAGEAL REFLUX DISEASE NAPROXEN TAB 500MG 500 NDC CODE:68462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA N O.:-78-250 THERAPEUTICE USE: -ANTI-INFLAMMATORY, ANALGESIC CARVEDILOL TAB 6.25MG 500 NDC CODE:68462016305 FDA PRO DUCT CODE NO : 62 O C A 22 H . T. S NO.: 3004.90.92.20 AN DA NO.:- 78-251 THERAPEUTICE USE:-BETA- ADRENOACEPTOR AN TAGONIST OXCARBAZEPINE TAB 300MG 100 NDC CODE:6846201380 1 FDA PRODUCT CODE NO.:-61 M C A 45 H. T. S NO.: 3004.90 .92.30 ANDA NO.:-77-802 THER APEUTICE USE:-ANTI CONVULSANT AGENT COMMERCIAL & CUSTOM INVOICE NO. F22352000899 DT. 03.06.2022 F22352000903 DT. 0 3.06.2022 F22352000892 DT. 03 .06.2022 F22352000896 DT. 03. 06.2022 F22352000897 DT. 03.0 6.2022 S/BILL NO: 1894018 DT 04-JUN-2022 S/BILL NO: 189391 1 DT 04-JUN-2022 S/BILL NO: 1 894077 DT 04-JUN-2022 S/BILL NO: 1893907 DT 04-JUN-2022 S/ BILL NO: 1894071 DT 04-JUN-202 2 NET WT: 7,640.13 KGS 02 DATA LOGGERS HUMIDITY:65% SE T TEMPERATURE : +18 DEGREES T EMPERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY: 2 GLENMARK PHARMACEUTICALS IN C 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA

4 PALLETS 357 CARTONS PHA RMACEUTICALS AS UNDER ROSUV ASTATIN TABLETS 10MG 90 S NDC CODE:68462026290 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO .: 079172 THERAPEUTICE USE: - TO TREAT HIGH CHOLESTEROL AN D RELATED CONDITIONS, AND TO PREVENT CARDIOVASCULAR DISEA SE COMMERCIAL & CUSTOM INVO ICE NO. F22352000775 DT. 29.0 5.2022 NET WT: 496.223 KGS 0 4 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RANGE : +15 DEGRE ES TO +25 DEGREES NOTIFY PART Y:2 GLENMARK SPECIALTY S.A. SWITZERLAND (GSSA) PLACE NUMA -DROZ 2 NEUCHATEL - 2000 SWI TZERLAND

55 PALLETS 3832 CARTONS PH ARMACEUTICALS AS UNDER OXCA RBAZEPINE TAB 150MG 100 NDC C ODE:68462013701 FDA PRODUCT C ODE NO.:-61 M C A 45 H. T. S NO.: 3004.90.92.30 ANDA NO. :-77-802 THERAPEUTICE USE:-AN TI CONVULSANT AGENT OXCARB AZEPINE TAB 300MG 100 NDC COD E:68462013801 FDA PRODUCT COD E NO.:-61 M C A 45 H. T. S N O.: 3004.90.92.30 ANDA NO.:- 77-802 THERAPEUTICE USE:-ANTI CONVULSANT AGENT ONDANSET RON TAB 8MG 30 NDC CODE:68462 010630 FDA PRODUCT CODE NO.: -61 T C A 28 H. T. S NO.: 300 4.90.92.40 ANDA NO.:- 77-535 THERAPEUTICE USE:-ANTI EMETI C VERAPAMIL HCL ER TAB 240M G 100 NDC CODE:68462026001 F DA PRODUCT CODE NO.: 62 O C B 13 H. T. S NO.: 3004.90.92. 20 ANDA NO.:-78-906 THERAPEU TICE USE:-ANGINA PRAMIPEXO LE TAB 0.125MG 90 NDC CODE:68 462033090 FDA PRODUCT CODE NO .: 62 J C A 15 H. T. S NO.: 3004.90.92.40 ANDA NO.: 90-7 81 THERAPEUTICE USE: USED IN PARKINSON#S DISEASE NAPROX EN TAB 500MG 100 NDC CODE:684 62019001 FDA PRODUCT CODE NO .:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA NO.:-78-25 0 THERAPEUTICE USE:-ANTI-INF LAMMATORY, ANALGESIC VERAP AMIL HCL ER TAB 240MG 500 NDC CODE:68462026005 FDA PRODUCT CODE NO.: 62 O C B 13 H. T. S NO.: 3004.90.92.20 ANDA N O.:-78-906 THERAPEUTICE USE: -ANGINA TELMISARTAN TAB 40M G 30 NDC CODE:68462020030 FD A PRODUCT CODE NO.: 62 O C A 09 H. T. S NO.: 3004.90.92.2 0 ANDA NO.:090032 THERAPEUTI CE USE: INDICATED FOR THE TR EATMENT OF HYPERTENSION, TO L OWER BLOOD PRESSURE PRAMIP EXOLE TAB 0.125MG 90 NDC CODE :68462033090 FDA PRODUCT CODE NO.: 62 J C A 15 H. T. S NO .: 3004.90.92.40 ANDA NO.: 9 0-781 THERAPEUTICE USE: USED IN PARKINSONS DISEASE COMM ERCIAL & CUSTOM INVOICE NO. F 22352000773 DT. 29.05.2022 F2 2352000774 DT. 29.05.2022 F22 352000776 DT. 29.05.2022 F223 52000777 DT. 29.05.2022 F2235 2000788 DT. 30.05.2022 NET WT : 8,872.81 KGS 02 DATA LOGGE RS HUMIDITY:65% SET TEMPERAT URE : +18 DEGREES TEMPERATURE RANGE : +15 DEGREES TO +25 DE GREES NOTIFY PARTY:2 GLENMAR K PHARMACEUTICALS INC 750, CO RPORATE DRIVE, NEW JERSEY MA HWAH - 07430 USA S/BILL NO: 1772988 DT 30-MAY-2022 S/ BILL NO: 1772943 DT 30-MAY-202 2 S/BILL NO: 1772987 DT 30-MA Y-2022 S/BILL NO: 1799668 DT 31-MAY-2022 S/BILL NO: 180035 0 DT 31-MAY-2022..